Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2

doi:10.5501/wjv.v12.i2.132

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 2

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5034)

All Articles published online

The chart showing PDF series, WORD series, HTML series.

Item

Count

PDF

191

WORD

HTML

1940

Sum=2171

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

395

Download

1239

Sum=1634

Publishing Process of This Article

Item

Count

Browse

289

Download

948

Sum=1237

Mar 25, 2023 (publication date) through Mar 8, 2026

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Letter to the Editor

World J Virol. Mar 25, 2023; 12(2): 132-135
Published online Mar 25, 2023. doi: 10.5501/wjv.v12.i2.132

Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2

Ali Osman Gulmez, Sonay Aydin

Ali Osman Gulmez, Department of Radiology, Erzincan University, Erzincan 24100, Turkey

Sonay Aydin, Department of Radiology, Erzincan University, Erzincan 24100, Turkey

Author contributions: Aydin S and Gulmez AO conceived the study; Aydin S and Gulmez AO were responsible for designing, materials and supervision; Aydin S and Gulmez AO did the literature search, wrote the manuscript, and reviewed the manuscript critically; All authors have read and approved the final manuscript.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Corresponding author: Ali Osman Gulmez, MD, Academic Research, Department of Radiology, Erzincan University, Mengucek Gazi Education and Research Hospital, Başbağlar Mahallesi Hacı Ali Akın Caddesi No. 32 Erzincan/Merkez, Erzincan 24100, Turkey. aliosmangulmez.2@gmail.com

Received: October 19, 2022
Peer-review started: October 19, 2022
First decision: November 22, 2022
Revised: November 30, 2022
Accepted: January 5, 2023
Article in press: January 5, 2023
Published online: March 25, 2023
Processing time: 153 Days and 3.4 Hours

Abstract

The relationship between coronavirus disease-19 (COVID-19) and cardiovascular diseases has been an important issue. Therefore, cardiac biomarkers and cardiac imaging have an important place in the diagnostic phase. It is important to know the relationship of biomarkers in COVID-19 so that we can understand the diagnosis of the disease, the predicted course and results after diagnosis.

Keywords: Cardiac bioenzymes; Coronavirus disease - 19; Treatment; Diagnosis; Triple rule-out computed tomography angiography; Dual energy computed tomography

Core Tip: Recommends biomarkers, especially troponin, in patients with Coronavirus disease-19-associated myocarditis and other myocardial damage; however, they have proven that in addition to traditional biomarkers, new cardiac bioenzymes such as prepesin, copeptin also increase and significantly worsen the prognosis. Knowing this, evaluation together with other imaging methods is also important in diagnosis.